Not all patients with CLL need therapy. In spite of all the latest developments, the iwCLL continue to recommends watchful observation for individuals with asymptomatic condition.86 This recommendation relies on at the least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituxim